Covey Capital Advisors LLC Purchases New Shares in Amrize Ltd $AMRZ

Covey Capital Advisors LLC purchased a new position in shares of Amrize Ltd (NYSE:AMRZFree Report) during the 2nd quarter, according to the company in its most recent filing with the SEC. The institutional investor purchased 23,726 shares of the company’s stock, valued at approximately $1,176,000. Amrize makes up approximately 1.3% of Covey Capital Advisors LLC’s holdings, making the stock its 23rd largest position.

Other hedge funds have also recently added to or reduced their stakes in the company. Credit Industriel ET Commercial bought a new position in shares of Amrize in the second quarter worth about $109,000. Private Capital Advisors Inc. acquired a new stake in shares of Amrize in the second quarter valued at approximately $233,000. Cullen Frost Bankers Inc. bought a new position in Amrize in the 2nd quarter worth approximately $244,000. Virtus Family Office LLC acquired a new position in Amrize during the 2nd quarter worth $253,000. Finally, FNY Investment Advisers LLC acquired a new position in Amrize during the 2nd quarter worth $372,000.

Amrize Trading Down 1.8%

NYSE AMRZ opened at $51.90 on Friday. Amrize Ltd has a 12 month low of $44.12 and a 12 month high of $56.29. The firm has a 50-day moving average of $50.60. The company has a quick ratio of 0.85, a current ratio of 1.38 and a debt-to-equity ratio of 0.42. The company has a market capitalization of $28.71 billion and a P/E ratio of 66.54.

Amrize (NYSE:AMRZGet Free Report) last issued its earnings results on Wednesday, August 6th. The company reported $0.78 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.03 by ($0.25). The business had revenue of $3.22 billion during the quarter.

Insider Buying and Selling at Amrize

In other news, insider Jaime Hill bought 4,000 shares of the business’s stock in a transaction on Friday, August 8th. The shares were bought at an average cost of $46.40 per share, for a total transaction of $185,600.00. Following the completion of the acquisition, the insider owned 9,601 shares in the company, valued at approximately $445,486.40. This trade represents a 71.42% increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Stephen S. Clark purchased 5,000 shares of Amrize stock in a transaction dated Friday, August 15th. The shares were purchased at an average cost of $51.82 per share, for a total transaction of $259,100.00. Following the completion of the transaction, the insider owned 5,000 shares of the company’s stock, valued at approximately $259,100. This represents a ∞ increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. Insiders have purchased 1,124,000 shares of company stock worth $53,225,260 over the last ninety days.

Analyst Upgrades and Downgrades

AMRZ has been the subject of several research reports. Royal Bank Of Canada lowered their target price on Amrize from $61.00 to $54.00 and set an “outperform” rating for the company in a research note on Friday, August 8th. Wall Street Zen upgraded Amrize to a “hold” rating in a research report on Saturday, October 25th. Oppenheimer began coverage on Amrize in a report on Tuesday, September 9th. They set an “outperform” rating and a $62.00 price objective for the company. UBS Group raised their target price on shares of Amrize from $49.00 to $52.00 and gave the company a “neutral” rating in a research note on Tuesday, October 14th. Finally, Barclays initiated coverage on shares of Amrize in a research note on Tuesday, October 7th. They set an “equal weight” rating for the company. One research analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating and four have assigned a Hold rating to the stock. According to data from MarketBeat.com, Amrize currently has a consensus rating of “Moderate Buy” and an average price target of $58.14.

View Our Latest Report on Amrize

Amrize Company Profile

(Free Report)

Amrize AG focuses on building materials business in North America. The company was incorporated in 2023 and is based in Zug, Switzerland. Amrize AG operates independently of Holcim AG as of June 23, 2025.

Read More

Want to see what other hedge funds are holding AMRZ? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Amrize Ltd (NYSE:AMRZFree Report).

Institutional Ownership by Quarter for Amrize (NYSE:AMRZ)

Receive News & Ratings for Amrize Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amrize and related companies with MarketBeat.com's FREE daily email newsletter.